|
|
|
Special
Issue •
Cannabinoids
|
|
|
|
Rene Anikwue, John W. Huffman, Zachary L. Martin and Sandra P.
Welch
Decrease in Efficacy and Potency of Nonsteroidal Anti-Inflammatory Drugs
by Chronic Δ9-Tetrahydrocannabinol Administration
J.
Pharmacol. Exp. Ther., Vol. 303, Issue 1, 340-346, October 2002.
|
|
Blazquez C, Gonzalez-Feria L, Alvarez L, Haro A, Casanova ML, Guzman
M
Cannabinoids inhibit the vascular endothelial growth factor
pathway in gliomas
Cancer Res. 2004 Aug 15;64(16):5617-23.
|
|
|
Cristina Blázquez, M. Llanos Casanova, Anna Planas, Teresa Gómez del
Pulgar, Concepción Villanueva, María J. Fernández-Aceñero, Julián
Aragonés, John W. Huffman, José L. Jorcano, and Manuel Guzmán
Inhibition of tumor angiogenesis by cannabinoids
The FASEB Journal. 2003
March;17:529-531. Published online January 2, 2003.
|
|
|
Carracedo A, Geelen MJ, Diez M, Hanada
K, Guzman M, Velasco G
Ceramide sensitizes astrocytes to
oxidative stress: protective role of cannabinoids
Biochem J. 2004 Jun 1;380(Pt 2):435-40.
|
|
|
M. Llanos Casanova, Cristina Blázquez, Jesús
Martínez-Palacio, Concepción Villanueva, M. Jesús
Fernández-Aceñero, John W. Huffman, José L. Jorcano
and Manuel Guzmán
Inhibition of skin tumor growth and angiogenesis in vivo by activation of
cannabinoid receptors
J. Clin. Invest. January 1 2003,
111:43-50.
|
|
|
Teresa Gómez del Pulgar, María L. de
Ceballos, Manuel Guzmán, and Guillermo Velasco
Cannabinoids Protect Astrocytes
from Ceramide-induced Apoptosis through the Phosphatidylinositol
3-Kinase/Protein Kinase B Pathway
J. Biol. Chem., Vol. 277, Issue 39, 36527-36533, September 27, 2002.
|
|
|
Stig O. P. Jacobsson , Thomas Wallin and Christopher J.
Fowler
Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and
Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid
Receptors
J. Pharmacol. Exp. Ther., Vol. 299, Issue 3, 951-959, December 2001.
|
|
|
Paola Massi, Angelo Vaccani, Stefania
Ceruti, Arianna Colombo, Maria P. Abbracchio,
and Daniela Parolaro
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human
Glioma Cell Lines
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 838 - 845.
|
|
|
Cristina Sánchez, María
L. de Ceballos, Teresa Gómez del
Pulgar, Daniel Rueda, César
Corbacho, Guillermo Velasco, Ismael Galve-Roperh,
John W. Huffman, Santiago Ramón y Cajal and Manuel
Guzmán
Inhibition of Glioma Growth
in Vivo by Selective Activation of
the CB2 Cannabinoid Receptor
Cancer Research, 61, 5784-5789, August 1, 2001.
|
|
Velasco G, Galve-Roperh I, Sanchez C, Blazquez C, Guzman
M
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Neuropharmacology. 2004 Sep;47(3):315-23.
|
|
Thomas W. Klein, Cathy Newton, Kellie
Larsen, Lily Lu, Izabella Perkins, Liang
Nong and Herman Friedman
The cannabinoid system and immune modulation
Journal of Leukocyte Biology. 2003, October 1;74:486-496.
|
bottom
|